Renal injury in cardiorenal syndrome type 1 is mediated by albumin. Issue 3 (12th February 2022)

• Record Type: Journal Article
• Authors: Funahashi, Yoshio; Ikeda, Mizuko; Wakasaki, Rumie; Chowdhury, Sheuli; Groat, Tahnee; Zeppenfeld, Douglas; Hutchens, Michael P.
• Is Part Of: Physiological reports. Volume 10:Issue 3(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-02-12
• Subjects: acute kidney injury -- albumin -- cardiac arrest and cardiopulmonary resuscitation -- cardiorenal syndrome; Physiology -- Periodicals; 571
• DOI: 10.14814/phy2.15173
• Languages: English
• ISSNs: 2051-817X

Abstract

Abstract: Cardiorenal syndrome type 1 (CRS‐1) acute kidney injury (AKI) is a critical complication of acute cardiovascular disease but is poorly understood. AKI induces acute albuminuria. As chronic albuminuria is associated with worsening kidney disease and albumin has been implicated in tubular epithelial injury, we investigated whether albumin participates in CRS‐1, and whether CRS‐1 alters renal albumin handling. We report the role of albumin in in vivo and in vitro CRS‐1 models. An established translational model, cardiac arrest and cardiopulmonary resuscitation (CA/CPR) induced severe acute albuminuria which correlated with tubular epithelial cell death. In vivo microscopy demonstrated CA/CPR‐induced glomerular filtration of exogenous albumin, while administration of exogenous albumin after CA/CPR worsened AKI compared to iso‐oncotic control. Increased albumin signal was observed in the proximal tubules of CA/CPR mice compared to sham. Comparison of albumin flux from tubular lumen to epithelial cells revealed saturated albumin transport within minutes of albumin injection after CA/CPR. In vitro, HK2 cells (human kidney tubular epithelial cells), exposed to oxygen‐glucose deprivation were injured by albumin in a dose dependent fashion. This interference was unchanged by the tubular endocytic receptor megalin. In conclusion, CRS‐1 alters albumin filtration and tubular uptake, leading to increased tubular exposure to albumin, which is injurious to tubular epithelial cells, worsening AKI. Our findings shed light on the pathophysiology of renal albumin and may guide interventions such as albumin resuscitation to improve CRS‐1 outcomes. This investigation may have important translational relevance for patients that receive exogenous albumin as part of their CRS‐1 treatment regimen. Abstract : Administered albumin worsens AKI in cardiorenal syndrome type 1; this is associated with increased albumin filtration and altered tubular albumin uptake.